Results 191 to 200 of about 15,157 (219)
Some of the next articles are maybe not open access.
Langerhans' cells histiocytosis.
International journal of pediatric otorhinolaryngology, 1999Langerhans cell histiocytosis (LCH) is a rare disorder of unknown cause, characterized by the proliferation of histiocytic cells in various tissues and organs. The role of the otolaryngologist is important in the early and accurate evaluation, staging and diagnosis of LCH, because it may mimic more common diseases such as otitis externa and acute ...
SELLARI FRANCESCHINI, STEFANO +5 more
openaire +2 more sources
Pulmonary Langerhans’ cell histiocytosis
2007Pulmonary Langerhans’ cell histiocytosis (PLCH) is a diffuse, smoking-related lung disease characterized pathologically by bronchiolocentric inflammation, cyst formation, widespread vascular ...
Harari S., Caminati A.
openaire +3 more sources
2015
Langerhans cell histiocytosis comprises a set of conditions ranging from a localized form represented by a solitary lesion to a disseminated multiorgan involvement and having in common the microscopic findings of foci of proliferating Langerhans cells.
openaire +2 more sources
Langerhans cell histiocytosis comprises a set of conditions ranging from a localized form represented by a solitary lesion to a disseminated multiorgan involvement and having in common the microscopic findings of foci of proliferating Langerhans cells.
openaire +2 more sources
Biology of Langerhans Cells and Langerhans Cell Histiocytosis
2006Langerhans cells (LC) are epidermal dendritic cells (DC). They play an important role in the initiation of immune responses through antigen uptake, processing, and presentation to T cells. Langerhans cell histiocytosis (LCH) is a rare disease in which accumulation of cells with LC characteristics (LCH cells) occur. LCH lesions are further characterized
Robert J. Arceci, G I Bechan, R M Egeler
openaire +3 more sources
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly